SUSAN ABUGHOSH to Quality-Adjusted Life Years
This is a "connection" page, showing publications SUSAN ABUGHOSH has written about Quality-Adjusted Life Years.
Connection Strength
1.055
-
Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States. Expert Rev Pharmacoecon Outcomes Res. 2025 Jan; 25(1):63-70.
Score: 0.888
-
Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan. Expert Rev Pharmacoecon Outcomes Res. 2021 Aug; 21(4):829-836.
Score: 0.167